Showing results (561-570 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|November 19, 2016
Interleukin 10 expression is related to aggressiveness and poor prognosis of patients with thyroid cancerLucas Leite Cunha, Elaine Cristina Morari, Sueli Nonogaki, et al.Cancer Immunology, Immunotherapy : CII|October 23, 2016
Heterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategiesJoseph M Obeid, Nolan A Wages, Yinin Hu, et al.Cancer Immunology, Immunotherapy : CII|October 28, 2016
Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in miceJonathan M Eby, Levi Barse, Steven W Henning, et al.Cancer Immunology, Immunotherapy : CII|November 23, 2016
Immunogenicity and efficacy of a rationally designed vaccine against vascular endothelial growth factor in mouse solid tumor modelsAizhang Xu, Li Zhang, Yangyang Chen, et al.Cancer Immunology, Immunotherapy : CII|November 30, 2016
Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccinationNergui Dagvadorj, Anne Deuretzbacher, Daniela Weisenberger, et al.Cancer Immunology, Immunotherapy : CII|December 5, 2016
Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitroHai-Fang Wang, Fen Ning, Zong-Cai Liu, et al.Cancer Immunology, Immunotherapy : CII|February 21, 2008
Cancer treatment: the combination of vaccination with other therapiesMads Hald Andersen, Rikke Baek Sørensen, David Schrama, et al.Cancer Immunology, Immunotherapy : CII|February 21, 2008
TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor modelHiroyuki Inoue, Mutsunori Iga, Meng Xin, et al.Cancer Immunology, Immunotherapy : CII|February 7, 2008
Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brainRobert M Prins, Chengyi J Shu, Caius G Radu, et al.Cancer Immunology, Immunotherapy : CII|February 8, 2008
Local therapy of cancer with free IL-2Willem Den Otter, John J L Jacobs, Jan J Battermann, et al.Pageof 650